Venous thromboembolism in the get with the guidelines-stroke acute ischemic stroke population: Incidence and patterns of prophylaxis

G. Logan Douds, Anne S. Hellkamp, Daiwai M. Olson, Gregg C. Fonarow, Eric E. Smith, Lee H. Schwamm, Kevin M. Cockroft

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background: Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolus (PE), represents a serious complication in hospitalized ischemic stroke patients. This study examines the incidence of VTE and the patterns of VTE prophylaxis in acute ischemic stroke patients deemed appropriate for VTE prophylaxis (nonambulatory) in the Get With The Guidelines-Stroke (GWTG-S) study. Methods: We analyzed data from 149,916 patients who were admitted with acute ischemic stroke and enrolled in GWTG-S from 1259 U.S. hospitals. Patient variables and site characteristics were analyzed in relation to reported administration of VTE prophylaxis. Results: The overall rate of VTE prophylaxis in the analysis cohort was 93% (139,476/149,916). The median site prophylaxis rate was 95%, and prophylaxis rates ranged from 17% (1 site) to 100% (101 sites). Factors associated with increased likelihood of VTE prophylaxis in the multivariable model included history of atrial fibrillation/flutter, receipt of intravenous or intra-arterial tissue plasminogen activator, and admission to an academic hospital. Increasing age, black race, and a history of peripheral vascular disease, diabetes, or stroke were associated with lower likelihood of prophylaxis. Patients receiving care in the Midwest were less likely to receive prophylaxis compared to other regions. Conclusions: Despite a high overall rate of VTE prophylaxis, VTE was found to occur in approximately 3% of GWTG-S patients. Reported rates of VTE prophylaxis differed among hospitals by region and hospital type, and among patients by age, race, and medical comorbidities.

Original languageEnglish (US)
Pages (from-to)123-129
Number of pages7
JournalJournal of Stroke and Cerebrovascular Diseases
Volume23
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Venous Thromboembolism
Stroke
Guidelines
Incidence
Population
Cohort Studies
Atrial Flutter
Peripheral Vascular Diseases
Tissue Plasminogen Activator
Embolism
Venous Thrombosis
Atrial Fibrillation
Comorbidity
Patient Care
Lung

Keywords

  • Deep venous thrombosis
  • pulmonary embolus
  • regional variations
  • treatment variations

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery
  • Rehabilitation
  • Cardiology and Cardiovascular Medicine

Cite this

Venous thromboembolism in the get with the guidelines-stroke acute ischemic stroke population : Incidence and patterns of prophylaxis. / Douds, G. Logan; Hellkamp, Anne S.; Olson, Daiwai M.; Fonarow, Gregg C.; Smith, Eric E.; Schwamm, Lee H.; Cockroft, Kevin M.

In: Journal of Stroke and Cerebrovascular Diseases, Vol. 23, No. 1, 01.2014, p. 123-129.

Research output: Contribution to journalArticle

Douds, G. Logan ; Hellkamp, Anne S. ; Olson, Daiwai M. ; Fonarow, Gregg C. ; Smith, Eric E. ; Schwamm, Lee H. ; Cockroft, Kevin M. / Venous thromboembolism in the get with the guidelines-stroke acute ischemic stroke population : Incidence and patterns of prophylaxis. In: Journal of Stroke and Cerebrovascular Diseases. 2014 ; Vol. 23, No. 1. pp. 123-129.
@article{fa3a853727194c1480bc58e6d9c9ac56,
title = "Venous thromboembolism in the get with the guidelines-stroke acute ischemic stroke population: Incidence and patterns of prophylaxis",
abstract = "Background: Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolus (PE), represents a serious complication in hospitalized ischemic stroke patients. This study examines the incidence of VTE and the patterns of VTE prophylaxis in acute ischemic stroke patients deemed appropriate for VTE prophylaxis (nonambulatory) in the Get With The Guidelines-Stroke (GWTG-S) study. Methods: We analyzed data from 149,916 patients who were admitted with acute ischemic stroke and enrolled in GWTG-S from 1259 U.S. hospitals. Patient variables and site characteristics were analyzed in relation to reported administration of VTE prophylaxis. Results: The overall rate of VTE prophylaxis in the analysis cohort was 93{\%} (139,476/149,916). The median site prophylaxis rate was 95{\%}, and prophylaxis rates ranged from 17{\%} (1 site) to 100{\%} (101 sites). Factors associated with increased likelihood of VTE prophylaxis in the multivariable model included history of atrial fibrillation/flutter, receipt of intravenous or intra-arterial tissue plasminogen activator, and admission to an academic hospital. Increasing age, black race, and a history of peripheral vascular disease, diabetes, or stroke were associated with lower likelihood of prophylaxis. Patients receiving care in the Midwest were less likely to receive prophylaxis compared to other regions. Conclusions: Despite a high overall rate of VTE prophylaxis, VTE was found to occur in approximately 3{\%} of GWTG-S patients. Reported rates of VTE prophylaxis differed among hospitals by region and hospital type, and among patients by age, race, and medical comorbidities.",
keywords = "Deep venous thrombosis, pulmonary embolus, regional variations, treatment variations",
author = "Douds, {G. Logan} and Hellkamp, {Anne S.} and Olson, {Daiwai M.} and Fonarow, {Gregg C.} and Smith, {Eric E.} and Schwamm, {Lee H.} and Cockroft, {Kevin M.}",
year = "2014",
month = "1",
doi = "10.1016/j.jstrokecerebrovasdis.2012.10.018",
language = "English (US)",
volume = "23",
pages = "123--129",
journal = "Journal of Stroke and Cerebrovascular Diseases",
issn = "1052-3057",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Venous thromboembolism in the get with the guidelines-stroke acute ischemic stroke population

T2 - Incidence and patterns of prophylaxis

AU - Douds, G. Logan

AU - Hellkamp, Anne S.

AU - Olson, Daiwai M.

AU - Fonarow, Gregg C.

AU - Smith, Eric E.

AU - Schwamm, Lee H.

AU - Cockroft, Kevin M.

PY - 2014/1

Y1 - 2014/1

N2 - Background: Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolus (PE), represents a serious complication in hospitalized ischemic stroke patients. This study examines the incidence of VTE and the patterns of VTE prophylaxis in acute ischemic stroke patients deemed appropriate for VTE prophylaxis (nonambulatory) in the Get With The Guidelines-Stroke (GWTG-S) study. Methods: We analyzed data from 149,916 patients who were admitted with acute ischemic stroke and enrolled in GWTG-S from 1259 U.S. hospitals. Patient variables and site characteristics were analyzed in relation to reported administration of VTE prophylaxis. Results: The overall rate of VTE prophylaxis in the analysis cohort was 93% (139,476/149,916). The median site prophylaxis rate was 95%, and prophylaxis rates ranged from 17% (1 site) to 100% (101 sites). Factors associated with increased likelihood of VTE prophylaxis in the multivariable model included history of atrial fibrillation/flutter, receipt of intravenous or intra-arterial tissue plasminogen activator, and admission to an academic hospital. Increasing age, black race, and a history of peripheral vascular disease, diabetes, or stroke were associated with lower likelihood of prophylaxis. Patients receiving care in the Midwest were less likely to receive prophylaxis compared to other regions. Conclusions: Despite a high overall rate of VTE prophylaxis, VTE was found to occur in approximately 3% of GWTG-S patients. Reported rates of VTE prophylaxis differed among hospitals by region and hospital type, and among patients by age, race, and medical comorbidities.

AB - Background: Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolus (PE), represents a serious complication in hospitalized ischemic stroke patients. This study examines the incidence of VTE and the patterns of VTE prophylaxis in acute ischemic stroke patients deemed appropriate for VTE prophylaxis (nonambulatory) in the Get With The Guidelines-Stroke (GWTG-S) study. Methods: We analyzed data from 149,916 patients who were admitted with acute ischemic stroke and enrolled in GWTG-S from 1259 U.S. hospitals. Patient variables and site characteristics were analyzed in relation to reported administration of VTE prophylaxis. Results: The overall rate of VTE prophylaxis in the analysis cohort was 93% (139,476/149,916). The median site prophylaxis rate was 95%, and prophylaxis rates ranged from 17% (1 site) to 100% (101 sites). Factors associated with increased likelihood of VTE prophylaxis in the multivariable model included history of atrial fibrillation/flutter, receipt of intravenous or intra-arterial tissue plasminogen activator, and admission to an academic hospital. Increasing age, black race, and a history of peripheral vascular disease, diabetes, or stroke were associated with lower likelihood of prophylaxis. Patients receiving care in the Midwest were less likely to receive prophylaxis compared to other regions. Conclusions: Despite a high overall rate of VTE prophylaxis, VTE was found to occur in approximately 3% of GWTG-S patients. Reported rates of VTE prophylaxis differed among hospitals by region and hospital type, and among patients by age, race, and medical comorbidities.

KW - Deep venous thrombosis

KW - pulmonary embolus

KW - regional variations

KW - treatment variations

UR - http://www.scopus.com/inward/record.url?scp=84891791740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891791740&partnerID=8YFLogxK

U2 - 10.1016/j.jstrokecerebrovasdis.2012.10.018

DO - 10.1016/j.jstrokecerebrovasdis.2012.10.018

M3 - Article

C2 - 23253528

AN - SCOPUS:84891791740

VL - 23

SP - 123

EP - 129

JO - Journal of Stroke and Cerebrovascular Diseases

JF - Journal of Stroke and Cerebrovascular Diseases

SN - 1052-3057

IS - 1

ER -